Cita APA (7a ed.)

S, N., K, S., T, K., H, K., A, F., S, T., . . . T, S. (2020). Correlation of Immune-Related Adverse Events and Effects of Pembrolizumab Monotherapy in Patients with Non-Small Cell Lung Cancer. Dove Medical Press.

Cita Chicago Style (17a ed.)

S, Noguchi, Suminaga K, Kaki T, Kawachi H, Fukao A, Terashita S, Horikawa S, Ikeue T, y Sugita T. Correlation of Immune-Related Adverse Events and Effects of Pembrolizumab Monotherapy in Patients with Non-Small Cell Lung Cancer. Dove Medical Press, 2020.

Cita MLA (8a ed.)

S, Noguchi, et al. Correlation of Immune-Related Adverse Events and Effects of Pembrolizumab Monotherapy in Patients with Non-Small Cell Lung Cancer. Dove Medical Press, 2020.